Almudena Pérez‐Rodríguez

Author

Complexo Hospitalario Universitario A Coruña ORCID

Also Known As

A. Perez-Rodriguez, A. PÉREZ-RODRÍGUEZ, A. Pérez, A. Pérez-Rodríguez, A. Pérez‐Rodríguez, Almudena Perez, Almudena Perez-Rodriguez, Almudena Pérez-Rodríguez, Almudena Pérez, Almudena Pérez-Rodríguez

Publications

498

Citations

H-Index

Concepts

All Affiliations

Complexo Hospitalario Universitario A Coruña Universidade de Santiago de Compostela Complejo Hospitalario Universitario de Santiago Hospital Regional Universitario de Málaga Instituto de Investigación Biomédica de A Coruña

About

Almudena Pérez‐Rodríguez is an author at Complexo Hospitalario Universitario A Coruña specializing in public health, genetic epidemiology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	75
2	Public Health	2	2	75
3	Epidemiology	2	2	75
4	Immunology	1	1	31
5	Medical Laboratory Science	1	1	31

Almudena Pérez‐Rodríguez

Publications

315

Citations

H-Index

Page 1

	Year	Citations
Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: A case-control study Iskandar Tamimi, Tomás Ojea, Juan Manuel Sanchez-Siles, Journal of Bone and Mineral Research	2012	62
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients Nina Borràs, Javier Batlle, Almudena Pérez‐Rodríguez, Haematologica	2017	54
Molecular and clinical profile of von Willebrand disease in Spain (PCM–EVW–ES): Proposal for a new diagnostic paradigm Javier Batlle, Almudena Pérez‐Rodríguez, Irene Corrales, Thrombosis and Haemostasis GeneticsGenetic EpidemiologyPathologyVwf Novel MutationDisease Gene Identification	2015	44
von Willebrand disease R1374C: Type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia) Norma Penas, Almudena Pérez‐Rodríguez, J. Torea, American Journal of Hematology	2005	39
Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study Núria Fabrellas, Rosario Hernández, Isabel Graupera, PLoS ONE	2018	35
Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies Joana Costa-Pinto, Almudena Pérez‐Rodríguez, M. del C. Goméz‐del‐Castillo, Haemophilia Type 1Molecular Diagnostic TechniquesAutomated VwfMedicineInherited Metabolic Disease	2014	31
Unraveling the effect of silent, intronic and missense mutations on <i>VWF</i> splicing: contribution of next generation sequencing in the study of mRNA Nina Borràs, Gerard Orriols, Javier Batlle, Haematologica	2018	22
Acquired von Willebrand syndrome and mitral valve prosthesis leakage. A pilot study Almudena Pérez‐Rodríguez, Joana Costa Pinto, Esther Lourés, European Journal Of Haematology	2011	16
Autosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications Almudena Pérez‐Rodríguez, Aránzazu García-Rivero, Esther Lourés, Haematologica	2009	12

Page 1